FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

46843002: Xanthine (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
78078018 Xanthine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
784236011 Xanthine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
78078018 Xanthine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
78078018 Xanthine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
784236011 Xanthine (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
784236011 Xanthine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
373201000195113 xantina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
401581000274115 Xanthin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1138201000241113 xanthine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
1138201000241113 xanthine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
373201000195113 xantina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
401581000274115 Xanthin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Xanthine Is a Purines and derivatives (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a Simple physiological organic compound false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a Intermediary agent of metabolism (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a classe d'allergènes false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a Vasodilator (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a Drug pseudoallergen by function false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a allergène médicamenteux false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a Xanthine or xanthine derivative false Inferred relationship Existential restriction modifier (core metadata concept)
Xanthine Is a Xanthine and/or xanthine derivative (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Theophylline 400mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ephedrine hydrochloride 11 milligram and theophylline 120 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely ephedrine sulfate 15 milligram and theophylline 120 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 100 milligram and ergotamine tartrate 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine 65 mg and paracetamol 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 30 milligram and paracetamol 450 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine 25 mg and paracetamol 450 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Oral aminophylline The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aminophylline-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine- and paracetamol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 250 milligram and caffeine 65 milligram and paracetamol 250 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Ergotamine + caffeine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol+caffeine 500mg/65mg soluble tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine 5mg/mL injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine and sodium benzoate injection solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aminophylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing theophylline (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing theophylline sodium glycinate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine and dihydrocodeine tartrate and paracetamol The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely theophylline 10 milligram/1 milliliter conventional release oral solution (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 65mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 130mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 260mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin- and caffeine- and cinnamedrine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline + dextrose The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aspirin and caffeine and orphenadrine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing caffeine and paracetamol and salicylamide (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing buffered aspirin and caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin- and caffeine- and paracetamol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing aspirin and caffeine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 389 milligram and caffeine 32.4 milligram and dextropropoxyphene hydrochloride 32 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Butalbital 50 mg and caffeine 40 mg and codeine phosphate 30 mg and paracetamol 325 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram and codeine phosphate 30 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 250mg/2cc The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 160mg/15ml elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 100mg/15mL The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline 200mg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diprophylline 400 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline, anhydrous 80mg/15mL syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline, anhydrous 300mg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 100 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline anhydrous 200 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline anhydrous 400 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine citrate 20mg/mL injection (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 75 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline anhydrous 50 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline anhydrous 450mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 500mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 80mg/15mL elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely theophylline 75 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 100mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 125 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline anhydrous 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline anhydrous 400 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 300 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely theophylline anhydrous 300 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine citrate 20mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Acetaminophen+butalbital+caffeine 325mg/50mg/40mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely butalbital 50 milligram and caffeine 40 milligram and paracetamol 500 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Acetaminophen+butalbital+caffeine 500mg/50mg/40mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely caffeine 100 milligram and isometheptene mucate 65 milligram and paracetamol 325 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 325 milligram and butalbital 50 milligram and caffeine 40 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin + butalbital + caffeine 325mg/50mg/40mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 385 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 428 mg and caffeine 30 mg and orphenadrine citrate 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely aspirin 770 milligram and caffeine 60 milligram and orphenadrine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 856 mg and caffeine 60 mg and orphenadrine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/50mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 200mg/100mg capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Diprophylline 200 mg and guaifenesin 200 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Ephedrine sulfate + hydroxyzine hydrochloride + theophylline 6.25mg/2.5mg/32.5mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 100mg/150mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 100mg/80mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 200mg/150mg solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 90mg/150mg syrup The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline sodium glycinat 100mg/300mg elixir (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline, anhydrous 90mg/150mg liquid The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Potassium iodide + theophylline, anhydrous 130mg/80mg elixir The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline, anhydrous 100mg m/r tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aminophylline 25mg/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aminophylline 25mg/mL injection solution 10mL amp The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Aminophylline 250mg/10mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)
Theophylline 300mg m/r capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Xanthine Inferred relationship Existential restriction modifier (core metadata concept)

Start Page 2 of 3 End

This concept is not in any reference sets

Back to Start